Congrats. It sounds like you all have additional teammates to help push patient profiles. Reach and frequency gets it done every time. EVERY TIME. Laser focus. LASER FOCUS.
extremely risky move for Takeda, as reflected by thier stock price cratering. So much debt, reminds me of Teva and allergen deal.
This whole deal reminds me of those scenes where a kid comes up to the counter of the corner store with change in hand and asks “what can I get for this many?”. The store owner says no so the kid scrapes up couple extra coins from the couch cushions and comes back. Except he accidentally ends up buying the whole store and doesn’t have the capacity to run or manage it and doesn’t know what to do with it.
